0001493152-24-025493.txt : 20240628 0001493152-24-025493.hdr.sgml : 20240628 20240627195556 ACCESSION NUMBER: 0001493152-24-025493 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240628 DATE AS OF CHANGE: 20240627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTRICITY INC. CENTRAL INDEX KEY: 0001630113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 472548273 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40761 FILM NUMBER: 241080978 BUSINESS ADDRESS: STREET 1: 203 REDWOOD PARKWAY STREET 2: SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 832-1626 MAIL ADDRESS: STREET 1: 203 REDWOOD PARKWAY STREET 2: SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: METASOLUTIONS, INC. DATE OF NAME CHANGE: 20150107 10-K/A 1 form10-ka.htm
true FY 0001630113 10-K/A 0001630113 2023-04-01 2024-03-31 0001630113 2023-09-30 0001630113 2024-06-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

(Amendment No. 1)

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended: March 31, 2024

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 000-56074

 

BIOTRICITY INC.

(Exact name of registrant as specified in its charter)

 

nevada   30-0983531

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification)

 

203 Redwood Shores Parkway, Suite 600
Redwood City, CA 94065
(Address of principal executive offices, including zip code)

 

(800) 590-4155
(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Class   Trading Symbol (s)   Name of each exchange on which registered
Common Stock, Par Value $0.001   BTCY   Nasdaq Capital Market

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of Each Class   Name of Each Exchange On Which Registered
N/A   N/A

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such fi les). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer ☒ Smaller Reporting Company ☒
    Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: $16,344,389.

 

The number of shares outstanding of each of the registrant’s classes of common stock, as of June 25, 2024, was 21,484,396 (not including 160,672 Exchangeable Shares, directly exchangeable into an equivalent number of shares of common stock).

 

DOCUMENTS INCORPORATED BY REFERENCE

 

None.

 

Auditor Name   Auditor Location   Auditor Firm ID
SRCO Professional Corporation   Richmond Hill, Ontario, Canada   5828

 

 

 

 
 

 

Explanatory Note

 

The purpose of this Amendment No. 1 (the “Amendment”) to the Annual Report on Form 10-K of Biotricity Inc. (the “Company”) for the year ended March 31, 2024 (the “Original Form 10-K”) is to re-file the consent of the Company’s independent registered public accounting firm. In connection with the filing of this Amendment, the Company is also including with this Amendment certain currently dated certifications. Except as otherwise set forth in this Explanatory Note, no other information included in the Original Form 10-K is amended or changed by this Amendment.

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

Exhibit   Description
3.1   Amended and Restated Articles of Incorporation (filed as Exhibit 3(i) to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
3.2   Amended and Restated By-Laws (filed as Exhibit 3(ii) to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
4.1   Certificate of Designation of Preferences, Rights and Limitations of Special Voting Preferred Stock of Biotricity Inc. (filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
4.2   Exchangeable Share provisions with respect to the special rights and restrictions attached to Exchangeable Shares (filed as Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
4.3   Form of Secured Convertible Debenture due September 21, 2017 (filed as Exhibit 4.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
4.4   Form of Warrant (filed as Exhibit 4.4 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
4.5   Form of Convertible Promissory Note (filed as Exhibit 4.5 to the Registrant’s Transition Report on Form 10-KT filed with the SEC on April 13, 2016 and incorporated herein by reference).
4.6   Form of Warrant (filed as Exhibit 4.6 to the Registrant’s Transition Report on Form 10-KT filed with the SEC on April 13, 2016 and incorporated herein by reference).
4.7   Form of Warrant (filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 9, 2017 and incorporated herein by reference).
4.8   Form of Placement Agent Warrant (filed as Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 9, 2017 and incorporated herein by reference).
4.9   Form of Promissory Note (filed as Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 9, 2017 and incorporated herein by reference).
4.10   Form of Promissory Note (filed as Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on July 12, 2019 and incorporated herein by reference).
4.11   Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of Series A Convertible Preferred Stock (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 20, 2019 and incorporated herein by reference).
4.12   Promissory Note between Biotricity Ic. and Cross River Bank (filed as exhibit 4.12 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 filed with the SEC on July 15, 2020 and incorporated herein by reference).
4.13**  

Description of Registrant’s Securities

10.1   Exchange Agreement, dated February 2, 2016, among Biotricity Inc., Biotricity Callco Inc., Biotricity Exchangeco Inc., iMedical Innovation Inc. and the Shareholders of iMedical Innovations Inc. (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
10.2   Assignment and Assumption Agreement, dated as of February 2, 2016, by and between Biotricity Inc. and W270 SA (filed as Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
10.3   Voting and Exchange Trust Agreement, as of February 2, 2016, among Biotricity Inc., Biotricity Callco Inc., Biotricity Exchangeco Inc. and Computershare filed as Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
10.4   Support Agreement, made as of February 2, 2016, among Biotricity Inc., Biotricity Callco Inc. and Biotricity Exchangeco Inc. (filed as Exhibit 10.4 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
10.5*   2016 Equity Incentive Plan (filed as Exhibit 10.5 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).
10.6   Exclusivity & Royalty Agreement, dated as of September 15, 2014, by and between iMedical Innovation Inc. and CardioComm Solutions, Inc. (Filed as Exhibit 10.6 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 3, 2016 and incorporated herein by reference).

 

 2 
 

 

10.7*   Employment Agreement dated April 12, 2016 with Waqaas Al-Siddiq (filed as Exhibit 10.7 to the Registrant’s Transition Report on Form 10-KT filed with the SEC on April 13, 2016 and incorporated herein by reference).
10.8   Form of Subscription Agreement for convertible promissory notes and warrants (filed as Exhibit 10.8 to the Registrant’s Transition Report on Form 10-KT filed with the SEC on April 13, 2016 and incorporated herein by reference).
10.9   Investment Banking Agreement, as amended (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 9, 2017 and incorporated herein by reference).
10.10   Form of Subscription Agreement (filed as Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 9, 2017 and incorporated herein by reference).
10.11+   Software Development and Services Agreement, dated as of September 15, 2014, by and between iMedical Innovations Inc. and CardioComm Solutions, Inc. (filed as Exhibit 10.11 to the Registrant’s Transition Report on Form 10-KT filed with the SEC on June 29, 2017 and incorporated herein by reference).
10.12   Form of Securities Purchase Agreement (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 26, 2017 and incorporated herein by reference).
10.14   Form of Promissory Note (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 15, 2019 and incorporated herein by reference).
10.15   Form of Purchase Agreement (filed as Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 15, 2019 and incorporated herein by reference).
10.16   Form of Subscription Agreement (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on July 12, 2019 and incorporated herein by reference).
10.17   Form of Securities Purchase Agreement (filed as Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 20, 2019 and incorporated herein by reference).
10.18   Form of Exchange Agreement (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 13, 2019 and incorporated herein by reference).
10.19   Employment Agreement between the Company and Waqaas Al-Siddiq filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 13, 2020 and incorporated herein by reference).
10.20   Form of Subscription Agreement (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on August 6, 2020 and incorporated herein by reference).
10.21   Form of Convertible Promissory Note (filed as Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on August 6, 2020 and incorporated herein by reference).
10.22   Form of Warrant filed as Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on August 6, 2020 and incorporated herein by reference).
10.23   Form of Registration Rights Agreement filed as Exhibit 10.4 to the Registrant’s Current Report on Form 8-K filed with the SEC on August 6, 2020 and incorporated herein by reference).
10.24   Form of Subscription Agreement filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 22, 2021 and incorporated herein by reference).
10.25   Form of Convertible Promissory Note filed as Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 22, 2021 and incorporated herein by reference).
10.26   Form of Registration Rights Agreement filed as Exhibit 10. 4 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 22, 2021 and incorporated herein by reference).
10.27   Credit Agreement (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 28, 2021 and incorporated herein by reference).
10.28   Common Stock Purchase Agreement (filed as Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 28, 2021 and incorporated herein by reference).
10.29   Collateral Agreement (filed as Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 28, 2021 and incorporated herein by reference).
10.30   IP Security Agreement (filed as Exhibit 10.4 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 28, 2021 and incorporated herein by reference).
10.31   At The Market Offering Agreement, by and between the Company and H.C. Wainwright & CO, LLC, dated March 22, 2022 (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 22, 2022 and incorporated herein by reference).
10.32   Credit Agreement, by and between the Company and SWK Funding LLC (filed as Exhibit 10.1 to the current report under Form 8-K filled with SEC on December 28, 2021)
14.1   Code of Business Conduct and Ethics (filed as Exhibit 14.1 to the Registrant’s Transition Report on Form 10-KT filed with the SEC on April 13, 2016 and incorporated herein by reference).
19**  

Insider Trading Policy

21.1   List of Subsidiaries (filed as Exhibit 21.1 to the Registrant’s Transition Report on Form 10-KT filed with the SEC on April 13, 2016 and incorporated herein by reference).
23.1***   Consent of SRCO Professional Corporation
31.1***   Section 302 Certification of Principal Executive Officer
31.2***   Section 302 Certification of Principal Financial and Accounting Officer
32.1***   Section 906 Certification of Principal Executive Officer
32.2***   Section 906 Certification of Principal Financial and Accounting Officer

97**

  

Clawback policy

101  

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Indicates management contract or compensatory plan or arrangement.
+ Portions of this document have been omitted and submitted separately with the Securities and Exchange Commission pursuant to a request for “Confidential Treatment”.
** Previously Filled
*** Filed herewith

 

 3 
 

 

SIGNATURES

 

Pursuant to the requirements of the Section 13 or 15 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the day of June 27, 2024.

 

  BIOTRICITY INC.
     
  By: /s/ Waqaas Al-Siddiq
    Waqaas Al-Siddiq
    Chief Executive Officer and President

 

In accordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Waqaas Al-Siddiq   Chairman, President and Chief Executive Officer (principal executive officer)   June 27, 2024
Waqaas Al-Siddiq        
         
/s/ John Ayanoglou   Chief Financial Officer (principal financial and accounting officer)   June 27, 2024
John Ayanoglou        
         
/s/ David A. Rosa   Director   June 27, 2024
David A. Rosa        
         
/s/ Chester White   Director   June 27, 2024
Chester White        
         
/s/ Ronald McClurg   Director   June 27, 2024
Ronald McClurg        

 

 4 
 EX-23.1 2 ex23-1.htm

 

Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements of Biotricity Inc. on Form S-3 (No. 333-262288, 333-279226, and 333-279284) of our report dated June 26, 2024 relating to the audited consolidated financial statements of Biotricity Inc. for the year ended March 31, 2024 and 2023, which appear in this Form 10-K/A for the year ended March 31, 2024. We also consent to the reference to our firm under the heading “Experts” in the Registration Statements.

 

  /s/ SRCO Professional Corporation
   
  CHARTERED PROFESSIONAL ACCOUNTANTS
Richmond Hill, Ontario, Canada Authorized to practice public accounting by the
June 27, 2024 Chartered Professional Accountants of Ontario

 

 

 

 GRAPHIC 3 ex23-1_001.jpg begin 644 ex23-1_001.jpg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end EX-31.1 4 ex31-1.htm

 

Exhibit 31.1

 

BIOTRICITY, INC.

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF THE SECURITIES

EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

 

I, Waqaas Al-Siddiq, certify that:

 

1. I have reviewed this Annual Report on Form 10-K/A of Biotricity, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
   
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
   
  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
  (c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
  (d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
   
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
   
  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
   
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

Date: June 27, 2024  
   
  /s/ Waqaas Al-Siddiq
  Waqaas Al-Siddiq
  Chief Executive Officer
  (principal executive officer)

 

 

 

 EX-31.2 5 ex31-2.htm

 

Exhibit 31.2

 

BIOTRICITY, INC.

 

CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF THE SECURITIES

EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

 

I, John Ayanoglou, certify that:

 

1. I have reviewed this Annual Report on Form 10-K/A of Biotricity, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
   
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
   
  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
  (c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
  (d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
   
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
   
  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
   
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

Date: June 27, 2024  
   
  /s/ John Ayanoglou
  John Ayanoglou
  (principal financial officer and principal accounting officer)

 

 

 

 EX-32.1 6 ex32-1.htm

 

Exhibit 32.1

 

BIOTRICITY, INC.

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K/A of Biotricity Inc. (the “Company”) for the fiscal year ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Waqaas Al-Siddiq, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: June 27, 2024  
   
  /s/ Waqaas Al-Siddiq
  Waqaas Al-Siddiq
  Chief Executive Officer
  (principal executive officer)

 

 

 

 EX-32.2 7 ex32-2.htm

 

Exhibit 32.2

 

BIOTRICITY, INC.

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K/A of Biotricity, Inc. (the “Company”) for the fiscal year ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Ayanoglou, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: June 27, 2024  
   
  /s/ John Ayanoglou
  John Ayanoglou
  (principal financial officer and principal accounting officer)

 

 

 

 EX-101.SCH 8 btcy-20240331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 9 btcy-20240331_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Name Auditor Location Auditor Firm ID EX-101.PRE 10 btcy-20240331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover - USD ($)
 12 Months Ended
Mar. 31, 2024
Jun. 25, 2024
Sep. 30, 2023
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description The purpose of this Amendment No. 1 (the “Amendment”) to the Annual Report on Form 10-K of Biotricity Inc. (the “Company”) for the year ended March 31, 2024 (the “Original Form 10-K”) is to re-file the consent of the Company’s independent registered public accounting firm. In connection with the filing of this Amendment, the Company is also including with this Amendment certain currently dated certifications. Except as otherwise set forth in this Explanatory Note, no other information included in the Original Form 10-K is amended or changed by this Amendment.    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Mar. 31, 2024    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2024    
Current Fiscal Year End Date --03-31    
Entity File Number 000-56074    
Entity Registrant Name BIOTRICITY INC.    
Entity Central Index Key 0001630113    
Entity Tax Identification Number 30-0983531    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One 203 Redwood Shores Parkway    
Entity Address, Address Line Two Suite 600    
Entity Address, City or Town Redwood City    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94065    
City Area Code 800    
Local Phone Number 590-4155    
Title of 12(b) Security Common Stock, Par Value $0.001    
Trading Symbol BTCY    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 16,344,389
Entity Common Stock, Shares Outstanding   21,484,396  
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Auditor Name SRCO Professional Corporation    
Auditor Location Richmond Hill, Ontario, Canada    
Auditor Firm ID 5828    
EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 14 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 17 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 3 39 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://biotricity.com/role/Cover Cover Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentType - form10-ka.htm 23 btcy-20240331.xsd btcy-20240331_lab.xml btcy-20240331_pre.xml form10-ka.htm http://xbrl.sec.gov/dei/2024 true false JSON 20 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-ka.htm": { "nsprefix": "BTCY", "nsuri": "http://biotricity.com/20240331", "dts": { "schema": { "local": [ "btcy-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "labelLink": { "local": [ "btcy-20240331_lab.xml" ] }, "presentationLink": { "local": [ "btcy-20240331_pre.xml" ] }, "inline": { "local": [ "form10-ka.htm" ] } }, "keyStandard": 39, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 4, "http://xbrl.sec.gov/dei/2024": 4 }, "contextCount": 3, "entityCount": 1, "segmentCount": 0, "elementCount": 64, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 39 }, "report": { "R1": { "role": "http://biotricity.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-04-01to2024-03-31", "name": "dei:AmendmentDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-04-01to2024-03-31", "name": "dei:AmendmentDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-ka.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorFirmId", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorLocation", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorName", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r11", "r13", "r14", "r16" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r20" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r17" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r18" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://biotricity.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r19" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r20": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 21 0001493152-24-025493-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-025493-xbrl.zip M4$L#!!0 ( /N>VUCX%#L7+ , .D+ 1 8G1C>2TR,#(T,#,S,2YX M],_T'UNVTPS04"R22D=.B0-@FYOW1D>P$-1G(EF4N_OI)O M7 P$:,N3O'O.V5WOKDS]8CH*T!BX((PVC+)5,A!0C_F$]AO&8]>\[#;;;0-= MG'_\@-2O_LDT48M X-?0-?/,-NVQ,_0=CZ"&O@(%CB7C9^@)!Y&VL!8)@*,F M&X4!2%".)%(-'5F.XR'3W$'W":C/^.-].]<=2!F*FFU/)A.+LC&>,#X4EL=& MNPEV)9:1R-5*TU+ZVXU^0X27DZO'-Z$XF=Z3ES[0T^@:TXEXQJ0%[FWU]]'; MJ0/#P?CYRG;?AK@R>QWVGZYN+[OX[LO)I7-Z5_J6A*P+;P CC%0SJ&@8NKZT MO$G%8KQO.Z52V7ZYZ71CG)$ :]. T.$Z>+E:K=JQ-X,6D%.7!YETQ=9N%PO( ME967;,$3*B2FWA+>ESEA$7QD)\XE*%D+/4Z@)(/ZL((3X%E]-K:50^&=SQDP M$F8?XS '][!P8]'4L0067!:!RK@*,N4L!+$6FKB6"%1^D'C,18@_>U4:9P$\J/21/JBMVA1$N^TF4W>#@8C?,)+C@EPF MZ$./4!('3_>HC$R]-9$N51UC9MU>!1>5(@'^#WH>GT,.0M'CHCK*D/)3R':N MAP,O"@ZBSO/;QDSMV:LLO.-LG>ZAA^(UK.F!:1B"Z(O02&T##KV&X4IO9F8= M_:G*MM1 91 =8?5_:NK=M=FGP% M.LR+I;90]).9\4QM,LN.62E;4^'/,]TGB?D;V"^)C'= $AMN]'7QQ2:X/L0C MM&O0#5^&K4'7P^!WYBQQBF;V26&JG+[FM);2H8ZH^ZD_5IG3> M8\;/XJ A\%A$)9_M,PB+E.SAL&[,_P'LUH@,GS1!_RDX-.P!4U ,OFX$ZG:B MIHY_ %!+ P04 " #[GMM8V#>/<;P+ #CD %0 &)T8WDM,C R-# S M,S%?;&%B+GAM;,V=76_CN!6&[POT/[#N30N,X\39+I#L9!<93[PP-IND<6:V M[:!8T!+C")'%@)(3Y]\O*8FR^'$D)45)SL6,QWP/]5)\3%(227W\:;=)T3-A M>4*SL]'1P>$(D2RB<9*MST9?EN/SY6RQ&*&\P%F,4YJ1LU%&1S_]^.<_(?[G MXU_&8S1/2!J?HL\T&B^R>_H#NL(;499#0EM^0>E<4\+5Z?.$IY(D@8U=\],')O-Y,R-A'QDXRL<4%B<: 3<:"C M[\6!_EI_?8E7)!TAH>1\@.4Z4?*J@R:NS=X0EM#X(GN?:SW:DWW^VV'%_U" M=KSS(MS1 J?O,M^.=&[[BKSOC._CW)]IWLZ3]YWI5N3_Q79A6G[SZ;6?UU1\ M>Q"K]G=&,];%UJ:DG\/5TU\=5IX8< C"HR1G*Z91%Y M4ZVTW4)GJ7:T2;E"#*E(-OZR'/U8:M WJ?KOQ\D^%P<5S8= VPW)BCN>HZ4$ M:K*K:K:9DK7<3@NBDBV&]#J6$B0TCBOXG!\X%@>?IWAML:^ENZIBJRU9QTIB M$)5LZ$PE*ZY *SJ M:&BRH.BP>P,!:>1^&;EC.,L3T8#U0F)*G5]N &:-2P]-%Q0G@#GXDJ31^R5E M^4#25#P/P%E_@V(3NZ8%-JSS8BJ#(@:T!S)31J Z)!QL+I[%Z)P/DP86MJ7W M"8]ANXN?1APL0KK#@12584C$>2*I]1BBAR%#Z9H>P*K.C28+BAB[-Y"52HY* MO7](+K)X$"*-S@\@FDT['K4H0#A49WUH<+5/,.9)'N&T\C+GW^4=Q;-H70," MVM4A,81!@0*Y V&I B0S98A78/Y-,!N&2TOI!Q;#JAV51A8@*+JW/DR$W@LD MLRUCBFNXQX&ESA[*]IAMGL\"NB! Z3%G/+6MY HHGGJ@BZQ(BEH,"0BP(3X!S)30#]6<%$3%.IXR R1R\$+<>1SS M$Y77_UPF&3D"RV_5NJ6KPZ[*E$48$$FP.X"?6OE!?D B!EUGH4 S?4-1I_ZA MF0Z%9AHT--/W0'/W0@.!YO@-13WV#\WQ4&B.@X;F^%W0\(KWVM;,^,=K=D=? M;).S0:479$RK5F#VLO!P,;SUP2("Q'A&A/C$I!Q87;,;1I^3+(*'S)#<"S" M:2LUFC8\=.P&^_AI!L0RSFM;4PW*>W\D4N:GE5%-VIN82A,>)*JQWL:E4OM$ MXH;F!4[_DSQU7HC;Q5[PL!JV0J(HPT/%9J\/F"H&\2 ?%]8UKN*!AG4IF9;N M;@FPQ=9^"7 K,0@(;([,)<#5W9-*Y+J:!:.,8*!%4).=5;+%5%/'K;0PJM@T M9-1P^;OF&A\_9+&[2WKS0#-X@H I<573D#E9VWIZ$#4.F-)KO92A4N?I;KS8 M82*W-]^M-&<]NVZGZ,(Y:$:@*066,7VP6>;XE[$WP6$(\(02:!T R]"'B!)GLA:H*],G6 MDD1;WC^^'DU7=TF1VBXN38FS/@DPU_1(6GH0; "F=!;*-$3OT='T;ZN_(QGE MN/JOZ!W#8O/8Y>MF15-@]RFKRA4$'18E!Q9)$"C OG0:KBBJI:C2^MB=2C%K M*8Z6[@H JRU9]4IB$)5NO^0<#:VR!@W3,(6(ADW@?JM+U[?2JPD8OY$T_26C M+]F2X)QF)*[NI=B>%'7KW2,UO+!.C%]$\DP^XP+7WL#R M0G+7BRJ[3.NK*6W:@!#J- BNGVQBQ%8Q6#+E;.:20!X6'SU;&##$-2ZX6%Y0:GZ:=MGF0DASLB3>66!:M%E05%$A +-E\ M"Z442:T7%BXVA*UY]_8SHR_%0[T_*U@V0.V6C4[+*B-6:4"L=/D#F)$AJ(J1 M6^KZ@6>WWU"\VF41+JE%ZA@;T*S&C*$+"1C(G$%+2B)QO^6*%NB.HB\Y0<4# M01?U:^C:.\%7^?AZTT@4B041U:@\BS&S(=0E=O[6$="P\>X10QD$2+WVX/>0 M-!%(ACBFYIHSS-K7<:6)14$VX&J'_A!7! TU+SGJTP=!TT"3.E-EF'IQ708B M$>ES-Z/VYO;P$$\1.1X96PQJ ^.6(@A&0%O0L+C]K@ _>^=M5VD2S5.*X;LL MBL;QCGFF/6VSO+T@( ),5] 6>:40E4HO]?\)9X]L^U1$KS>,1H2(659YTUKU MW7\;&.V6F3<52:5I4&A G+W%+T#@/@O4RN-#J\?R>3-/3!H7N[G1Z''Y@/D) MO-X6N>A!N3'X+GAGD./'"P,*H#UDZ(@("+T!-J$'#F4D*D,_H"H8M:(]79_E M^UT 2?SI]9;<$R;6'=R17?&)'^BQXPIC0*SKJ[?!Q=$OYGH#@X#PK6ZA2[T< MM3- *S%'K,X"?1.9H#(7U^\O7T3WK)Q(0MEY41#^TR@G,=E7&W2)76'7;UAR M!BN# *O7GD[28C:_174$:H7X6)"P?R\(;YDWQ05CE,TH[[ZC#GR&!+E_-TM? M U@E M!4&&Z<%#O6AQ98?P.QV0^&XBG5K6C7+Y)"J6O,$5;>4^:GR><(V M"]LC"BW=<76KMK3*KA)#JFK%$5310H06GRWUW/[JDG_B7\NO^%\KG!/^S1]0 M2P,$% @ ^Y[;6.R0\?/ !P WEX !4 !B=&-Y+3(P,C0P,S,Q7W!R M92YX;6S-G-]SVC@0Q]]OYOX''_=,"*3M7=+D.@D-':9IDPMI>WE9](D*JHB1ZGWTG?#,'9$#QJF*^C*=]3KQ5&[ M#:CW.Q6)5-_NA]MZ9\;,]5FGLU@LCH1\(@NI'O51+%-8A2-#3*:WM1TOC]<_ M1?%SSL3CF?LU)II&EI?09TO-+EJNW76SBY,CJ::=WO%QM_//EYM1/*,I:3/A MN,6TM2GE:JDJUST]/>WDWVY,#RR78\4W;9QT-NYL:[;?LH#]CB>:G>G3B+WUT9OV^J82:-8 MS,S*A:SCON[TI3TEK:]YP9FBDXO6V,0K6W_OS?%)4?OO)2.SFMM34S-W9K6B M3JGEN:*:"I.+O;$'2D7HTM@3BB:;BES[<-\,,\Y\?<)TH[8[N[+4MF8_%I9K M5S;.5Y_3^MS9Y)IP&O-B0>;(W53I4M]GW:#=NEBB.I$JHLZTU=1,6E8!V> MG&N+SIPH6U$[GC&^C?-$R=1'9TU">AS=!66;:(;FI6T_<3X,.)E6X]PS ?+L M8@"M5(-%]"/5L6)SQZ4&;,D2R+>'RK="6\.8-]?./9TRYZ]SQ=URJ3L8[A<\ M18#@3S![BJ!:I A<"I$1?D_G4M6 +UL">;_!Y%VE#0GSWQE1ABJ^@I ^, ;" M?HL)VZ,0B?>#(D(SQP<"_- :2/P=ZH.'1R,2\M&,,!T37G@TL,=T&'>%.10Y2LY9*Q,5^[^4*##T M'6,H."VS M/K2",D9).GVB4-AN1AJ$<=,9(;[[EE#&*+EF2!P*Y[[5HP@?BH0N/]-5"/2! M*90T2HX9E(>"^DZQE*C5B,7UG<:A+10V2F89%HA"^X$LAXE5Q2:LF!"LA^XM M F6/DE:"Y**$8"ABJ>9R9[BX+S-[/:[Z,@EVZ34%H>% R3=?(!TE*)=)8G'I M]9\;)F@W%(I*<_ <$5X C)?"?;>R[#WX-A1\M!:F:\$^\G+L)_ L:/DHK4R M,;'W[<=;]2 7GAEHKS$4.4HN6B,1$WA^I[E5=TH^L6)=5!WU@Q)0](@I:E@L MZ@E?W.0A9_O&$LH;,5VM%H?)^4YJ0_A_;%[W)%EM#V6.F+B&A#8]P%C$W0U: M^)82[9E ^:+DJI5RFD;J(JPH\9^^90LH4)0$M$I,PSQOI)O[F$D1'(\]M()R M1M"7:9J)]1B-9U;,8PK% MBY+^!>4UC'HDN5O=SL3TBWU"5(SP:LY5=E#(*,F>7UC#A.\4=9&F]K$[7\?E M]AJHV\G$U_.&[*'$47*]>J&XY(=:9U2]E']%*6@44-(^J.BF^QD:9[;;6W5[ MXP>W8\;3RQQ805FCI'P^40VS_2H?%''[]4:K="RY?WM(I2&4,$J"%Y#6,.22 M']5X]TR@8%$RNTHY2'W"]3*>$3&E_M4+U990P"B97D@<6M\[!?6]TQ?VO2@9 MGT\4$MMB;;B]HF['G$V)?R=9L !XGPTF\8#4IO?OY5M^W$YNE>9^#.R':NP> M4RAPG"V2(7E-H\X29FA2N#1@@HC8IE3;?6V>[+R^%#0 .'LH@:)1AO=_4,X_ M"[D0(TJT%#0I'O5#(_S>(M H(,XAULA%"<%WR3-+2>4+097G&O"80I$CSAUZ MY.&LO2P6-6_O/<4K.T+$?26@X!$G$<-BD=:G&>I\9D_T(S%D[6&(OZ\$E#_B MA&)8+-KZ>=6W-YZI#,^9[QE":2,NA:V4A@)YE!+.KS+-!-7!OF7/$ H9< E#HB"M;@U)QX"^?]Y$7^]^"Y"NLP6\G M0,3N%8GUVHTX=@LIBCNY2(CR4 _90[FC;JST"VV8_*V94;7[_)0[,[1Y6VC1 M0WTI:!10TE6H:)Q[Z\Y._N"MM60'Y8V8F%8)P]DSE8TYBP=Z$63J]4]G5#EEBD\T*6Y ML@T]AA^* ,6A\4%]HQ 80\-A&L83E0]X2W5I#-4%-O]B@I ]-! H"7&]4+37 M@-@+-S772DG5E[83C<,1@)2#1@+U?4/UPC%FNZ3R+T@H&8!?'XVUC>:\EVV , !$7 * 97@R,RTQ M+FAT;>U876_;-A1]-^#_<&>@00=8EC_:-+,5 [(L)]H4VY"4%7T::(FRV7GN.:1\).,\N'"']9IQ;IMC/$/^,P(G M<.VAH9=G[-5WW<9H-GX'?O#.M4\;L>"J#YUVJB!@:YK!E%Z!)]:$-\N&)OA4 MLKB! W'H_+[C!K FP"*7BN-)&S)^R#9 MJ_-8"GV_R12+MT]>S,.:\D*_<4&&=-NAUMZ=U_FBW M.ZWWZ;(!IAN<-C#FAYY/O$9K-O7M:5"OS2;@3,?VW,8#IO?L,\P_QR MY#H6F)8UNYP&SO0,)HYW\8QIJ71_EL6]I?7:BDJZV$(H>$:Y B5 K2@P'@J9 M"DD4$QRP7](8 WF8=Q41'EVR3.T"?$447>/X#$0,(R:49"%36W!XV (,F BY M!E_KP=&S)B8@9YMU@CC+EBI(H+_HHB3YLQ,"^3JE4V9$L M[NX0JO5,U_3M&S8P1ZX-ENVZ_MRT\+EUVF@WBONY.1Y7]_%@<'KS'(NFCE?%! MI?L:Z0]-_F]-K'/3*TQB"7#NS2:V[SNSJ>E6?M&%2".6=) MTH095T0RT02+8X,,F=^,X< "S-+<&61]JN8H_S MMIUKK-I&"0G_A$[K-7)9O+E@I7OS>FA6;YK9W:1_ZT)ON-6O[=!^D]ZR]6[] MOK1?XP>I]X16RZ9:,H:.Y%0\';"KY_26%/YGJ^KA7SGT_)-V^8T[_Q3^"5!+ M P04 " #[GMM8R,<.R5,( #'1@ "@ &5X,S$M,2YH=&WM7&U3XS@2 M_DX5_T%'U6Z%*H<$&.[JDFRJ\L9.;CE")9Z[G8^*+2'$!' MZ'KUK?V:)*)RQN.J%HL&@>;YA:G06D1WKX4L@%'K3:+9K:[2D,_B!I%\-M<' M[=;YZ-(M3E\-:,3#=>,I *:MXO]E%N]!^^=XJA;-5@T'A 6Z>D>FM;KMP>V< M3[G>WSL]/CINU;KM_Y>A1<,\%FLFWZ[37M<6\%)W.'+'P][0_>KL[PTO>T>E MIW;1EMY@[ [/A[V..QQ=[N]=?1E/OG1@;'=$QE\N!N3XE%://U7H(1F-R?&9 MGWTY)^[G 9D,>E_&0W+P==\+4[J]9/W8>#N/!__ MDRC-@_5+&C<$OOTWO:%4D4Y8G7#?YS<.+*+$B8B>4]WX,9:_O@?=3AX MN)A<=7K#RU]_.:@?F.]7G7X_^_[-MJZXK^?8M/Y3DTR%])FL>B(,Z4(!H.RW M R-,6^[XVR=8HG,\&F:[ E;U()6Y+;?_/P.N'YV<\?@EE_WX*%]RM_\]"%\[ M!BRT.5TR(MF2LQ7S8>MS"(DX3FA(QFPAI"8B)N="1M"K^ENM0T1 NEQHR3VN MUPX9QMY1LV@P_!COBI=?,9IVVK4/L;Y7KYR\D6#K4L5\"P_B*5J3ZUBL0N;/ MF&-C3MI@\P4,&PL-C!EKRF-"XS5)8BT31I2FFD7PH,<8I/#@@"<^AS@-J >7 M)!$1U^ :V^Y!@YAY3"DJUQ8%M(OH-8/)"P,KN.8#(I@WQ*04)\(&'I=>$D&S M&,8 .$#N9#7GWIRH!']L^J^89.D@:$7$5@Y5JP3Q$F:* P1< M4OA@,.PR8*#INK@@'V(3E]2RBUXY?1?4PDC 8XA;Y(%-G#K *SX1<%L6[O,X M@ <]U1S&X;$7)C[$(W!!(1X=(!,NPS590"@C%2%%A6'.-19'&N;JWOS :3[' MT1ULD830 A& &8.94!Y5$U)T$H5BICGS&;<:4EA=DH7K3@ :I3X ^5(3*0 M,W8I>617=^W'X9%/;X1'W#FSX#;Q]K-4-XEHJI0ITOP8G^8B"#A\-9$X)%0R M$_,0PWP:,HQ-PH!MIB%7,9(!S3$. G!/E-[.ZNP0]/?%-_PF_W*L2@26^;! M20AJC (A66Y 0(],9%$\F"VX,UL LZ'%][D*6F!RU?@(F[RDGM(KWX>U0@\M MN#Y3, ?$H M8APG49@*&>)-R1 S**/&A&* 28.40NL7%+=?$E*496">P;')JZ"'3=6*:2;\ M-F78$$03]&=^&0X[%@XE2>VB5RK3K23U;)WQ@*N>KU#N4I9%L9VWL"EPW9+[ MJ,JH$C%%4485L!A6<.#BC$H_XPD@+TZG/.1ZC1G7MKF1/0VE&+:PG%=L:M$4 MRD!& -ZFIBT2N0#*4B97]#PA?8/"%(1F+(;L+P3F@CML@:R(39)86W8"]N0+ M4%YE).Q8))3\M(M>J7@I/PV6-$R,R,"X94' /,V7$&QJ2UDE3_.>H9SLUTVE MY8ZL0":"CB!XD(A2V4*G(M&/PWB.P*-Y:X9EJ^#INC&98E4,"V)(LQ8(LVL" MR)HX0[EW=VOOEHRRBUZI^)GBL7'Z,.CQA"HMRY@[6YGE&W0.9EG"\Q*)4;W) M9QZM345":>B/;\# @ H\3FX2R(E@_,HC: (@*A ?]UJGZ#U@#G/"AH=OYB#< M@CLTT+)#"./LJ"Q/#1\4CW)\-/&Y%E+E MB9BY .-&$=>:L3^1=%,!J1[>]SF -(-4@*1 /"D\<8-/+&/!_)L#>7:3<##$ M\&D2>^9H[K"L8N_8?OXX#/.6O))7L3MA2+!4PX%(\#0(#Y<\SB#RTR0J+R2O M&+W&A,@62$Q*9(H\YI6>[&S\&7Q2T%"FX)MJ \FVRQ'J0V_%DI2'H M @0B)/"?2\3E$IE5W=LR2.[Z)6\T-R!["J0\+QW M(*J9T2G "^;=NI1 ')LR\7@IPB7#O"2FL_0]09E*&Q8M0K%F<'6'A1?_GZ[!= M4S4+]O[_PFK5ANW2>3\,EG5'EL+D/BG]\8-@]>:F1WBWS$CP](R-;G2K= M\L-@5=(W$[(J'LM]DU8.#S^(! 9+_E*MDG/.0K]!KB#Q:,( -PF+/>S8)*.% MJ1\VR 55FE2KF?_ZPW]EJ)ZRZZ]X[=[SJ;OE^;11XT7U?5^=IY,^*JOOR>^' M#Z]-@&T)F[N)(7H!>^1[M3#T9D&S'9+MCE8-%B=;I\+JUG!Y[1*^GPW4JN$? MHK%_F0;_@,T?4$L#!!0 ( /N>VUCC 8W$1 @ %Q% * 97@S,2TR M+FAT;>U<47/B.!)^3U7^@S95NT6J3"!DM-][?UQU#@_:[_MN#SX) M_FM[ ^^JWVG7["<\K66/V]UA[R,9>Q^O^K\>A5+H)CFMSS7Q>,P4N69+,I(Q M%8Z]X9 Q2WAX! VAZJ/! MQ<#[Z!P>#*XO3LJ5VD=?+OHC;W YN'"]P?#Z\.#FPVC\P86^O2$9?;CJD],S M6CU]5Z''9#@BI^=!?G%)O/=],NY??!@-O$%__#IFH__GQ7OW^K?^X8%[X:&3 MI_\Z>^<0=TSYPU=7_N)Z+ M1KW>V(?OE/^F2O-P]7(C^CL[-P "_EW.!'%75,AI)%,'-DV"PQ ]H[KY8_Q^ M_O7SW"XPV$7_ZFI\XUX,KG_[]:A^9*YOW%XOO_YB7Y<\T#,TK?_<(A.9!"RI M^C**Z%P!H/RW(Z-3V][HRP=8X.+X-,KW!,SJ4:9ZVU[O_P9Y7CED(/R35M%A^#':EU5^QFC:ZZ6]C_6UKDKCA01;ERH66'@0 M3_&*W JYC%@P98Z-N<0&6R"A6R$U,*;0E M"Q8JD0BZ%C!O0 0P;@1YJ@X M$!KX//'3&,P$] %P@-S)Q"8NJ64?5^7L55 +(R$7$+?( YLX=8!7 M B+A<5)XSD4(7_14<^B'"S]* XA'X()"/#I )CR)5F0.H8Q4A!0516NNL3BR M,%=WQ@=."SCV[J!%&H$!$(P$ C!C*@/*IVI&PD@N584=F_:F%H=7 M]I)C$4A8YL%!"&J, B%9;D! #PQD4=P;+=P:+831T..[7 46F%PUW\(F+ZFG M7)6OPUJAQQ9!_:0*4R%#O!D98@9EU)A4##!ID%+H_9SB]DLCBK(,W#,X-GD5 MM+"I6C'-A-\F# U!-$%[%I3AL&?A4)+4/JY*9;*3I)ZL,^YQU=,5RC9E612[ M>0M-@>L6/$!51I44%$495QI*,6P MA>6\HJE%4R@#&0'X.7-MGB9SH"QEK ME3%L26;[%C9OA\S.7W]YV[PB$^3\YVRT!>J=(OUL% 82R"-AG!^5K5/#>\6C M-3Z:!ES+1*T3,7,#^HUCKC5C?R/I)A)2/7P>< !I.JD 28%X4GCB!I]8QH+Q M-P?R[%/*P1'#IZGPS='<<5G%WK/]_'88YB6MRKJ*[481P5(-!R+!TR \7/(Y M@\C/DJAU(7G)Z"TF1+9 8E(B4^0QK_3D9^-/X)."AC(%WTP;)&RW'*$!M%9L MK48>Y)ZL- 1-@$!D OQG4C,%LZ#2.*8)N&\\RO3@SO<)2J6RKSNVY)%]7)5U MH=F%["I,X/O>@:AF1J< +YAWZS("<6S*Q,5"1@N&>8F@T^P]P223-BR>1W+% MX.ER)JV>H5OT!'3R-^F;A?)D_CG9O9MJYM7S3ODN_6.CO]1WZ<_K/W_+.>_! M!F]:5+^G@I'&/QW2J#?>?:,(?A[0)9WN':PWO 9>>0D.8FH?TM.3\X!IGD- MP?;ZO8&W!YV:JF61O?5_L-JU0:=<14&3W(#\;4$'GU)(M[%ABPSGIHK5)%=4 M:5*MY@O<&_PG1_687__ >W?XM'N73\'3C28L:L"[&G&;G^^+NSLB\#Z%;B)P M1UQMIR>X"MABO9D+76\F--\A^>YHUV!R\GDJS&X-I]=.X>O90.T:_G44^^=2 M\*^J_ ]02P,$% @ ^Y[;6'\'$(-!! :A$ H !E>#,R+3$N:'1M MU5AM<^(V$/Z>F?R'+3.7269L#"2Y]L#'C &G<6+Z&_ MOBN_) 22MC0OE^9#0)9V]]EG7[38//>_C/O[>^:Y;8WP$]2?Z3O^V.Z;1OF) MNT:U;0[-=:/5 TENIDYA=X5*PJX5L] _X/$M[IC%])?WFH&_?+MB<23CN M--NF,>B_@K'?\TRR:/5R[N@R20LKU7*>2)DLM^P&E$LJ"B\'CNO/G*'C7VK@ M3(;-E_%T1QS?R/VA/?.=,V=H^8X[@>G%S+NP)C[X[ILC:?\ %TVO.6S"048# MV6L?G[:T-T=A>6"-W*EOC[XI&9X]+ +RJ?41W#/PSVWPK-G FMB>[OXVMB_! M&OIJI]-J=5ZA*E\Z*Y\N>X=#D'".$6<)AQLF%R 7%"S.#7+!)$,?"0_!O@T6A%]1 M0!M+EF4(&N'PXFA()(4%%13AK<,IG:C18(_1X%=R3="6%>L>"T-VK<%PP6B$ MZM&<9%\IN%'$ BH =2E5E4L:1D8HXC1(6O$H;TB8I!+] M63]='E&I52GWB)@33C/=O8WI"JQ JAV56AKN$]G]/_1]M)#*1VU4#QE&7*EL M-3NGC#?ZA^TC\-'[*L>B/(Y7F(O+-%;!5@FPOZ?8$?0Z9X(N43A3O&15KK:/ M#\D18&JU3P_#HSLN[_/E+EC\X-5SLGZI#$,4DSBIVZ^M8HIE?3G]4& MOJI&@>VN#A5>0(UJPC7]47VJ4G[:^H"CT)F+M]T:/CUC?](R0QK]$<:A"S_E MG$+G^[)?FH:24(/RZ#F::QKOE>&_V6[^[&SBOTN^);A:I@I[/37,8Q+\ >WF M*69/EL0L_">*3:=O9,;6M6,:3O^=\KX-]5W"?.+:?J=H#U/!L&FFV#7I'>2D MA'ST.&:CZ&K]9_;*?W7WHXWO=!W.&(W#+DS)%>VAHNN<\D!YT ,W+;IY%\8D MDZ#KM=\CYY<:VX-I6]U6&_/V1_5LHYH&CU33?2]?[]V;O?UA=6XWY8WFO5V6 M?YL1#TF+:51(;#98I?J>R3IV==Q, \FI>5ICUU#TEA0^VU@W-3C-900 ! = * 97@S,BTR M+FAT;>U946_B1A!^1^(_3)$N2B0; [E<[\"'9,"Y^,H!PD[5/"[V MN:76>] M;D)_?6>Q34@NU5VJI$FYH CBW=G9^6:^F1W;]EGP9=BM5NPSUQG@+^B/'7C! MT.W:5OZ+LU8Q;??&@POP@XNA^[$V%URUH=E(% 1L15,8T2N8BA7A1CY@@$\E MF]=P(2Z=/'1=!U9$+A@WE4C:@.+;@9E02JQNC\5TCEH;'5#T6IDD9@O>!LD6 M2U7KVJ?C4;"[O3DG*Q:OV]\R8".;LK]H;F^M>\!G:=*Q+:T0'339(VAVK^M> M+]F,J6KEN%5OV5:O^Q* AI0K*O^_07Q:+!BUGC<.IE[?"RZ,:L4;]>O_9>1> M(_6]6/KN-/!.O;X3>.-1M3(YG_KG#NH.QON!K_F^6CFO^_5^'0Y2&JI.\_BD M8>P'-L>O5IS!>!*X ]B[P/EN/Z?DA\8[&)]"<.:"[TQ[SLCUS?%O0_<"G'Z@ M9UJ-1NOU2'A:;+]GJ6+S]6."\WBU$@K.,2F9X'#%U!+4DH+#>49BF-)$2 4X M8OU@.B#GTF%"2A4RM#?!X6(=#O>H@CBXST>F+54+X^D!NKHYP5[E1 M.F=IB$K7E$B@/*(1?"$R7,)Q$T^G5J/UU@"2HE2,,UM+?!IFDBF&L B/P+T. MEX0O*. F*Y:FVFK\TY(141265%*T;]><'$1I#=IKP&>QY."L"1>+6&0&])>, MSN&4<<)#1N)J93R?LY!*#55K*A 92"^I0V! DLDT(UR!$M!\#U]7-PV%1")1 M"&97.!?1^53H]HF<$4Y30XCTBC7#MZR7]#)CDJ[0C%33(2T2 MM'E\2(X \ZEY*NR(8P M6-P581R+$,NK9$D\PB0R+Y$TU1PS]#2)8X2"QR>60&1@FB#I<"8OW45IU HC MME&MRS%*97%.49%0N=DSK59NE\WZ\\3AZ?D4.+VA"WUW./0G3M\;??I8:]0V MUQ-G,"BO'XSUBD5JJ44;;SHP$S*BT@Q%'),D18/*_VJ;9S)V,'WX!G_J4PR/ MXI*AZ-5:\83'#@;_VN"3QIO']/D J=C.K?J<<0JMGPW07<(V"L'@Y1E]ARAH M(GY-7TJHGA;I"S7K-0#? ;,H,V4YG<4D_ .:]1-CVIR;'DP4=Z>Z ]L* 0E# MD7'%^*(4.+H_>M:F;^GN]Q,:1/>3:>(]/8VC-DS(@G90P65&>:@7=F"<;)K5 M-@Q)JL TRZ /O%]+J[Z%]9T>NU,Y>_=4SIL^<; M9.4]N78["#HR>L66X#NJ;QQ:LJ9DC&VA>TB2U+6])^M%^TM77Z?X\#%3T0PZ2Z]N'?8EKX-R*: MK"M4ZWWX=[E5J=?__7^EQ&G?8L584=&2^V2 4U0S+:S)9/J12K7[Y?7#VVG1CJ%27U%X MXC:2S2Q4S=XJLP^\A0L9^Z6OJ!58-&\7M=RBU-1SDGBXB@Z[Q/2#QV5E1:"9 M]9#\.+N^F!6W@LO/BF8L VMF5S<&V&)3"#7E4X*4D@J>2E(FD7T5L=_3/?WA MR7J.4EG1K6=AR9H:O$#"S-W_B*R_I(LXQ),,7.2]\'IF$M5LT>^@J= MM2NWTU(=JEL&E:DU27I?Z52Z)P253E& M+6*=H 8>D&/TJ#R>H'J5_W G2-6[F]8_4O5CN7S%_@'"4"JUYL?9\SOHY9V_ M=W=N[]:O*%>#C[)"3A"?\74^?T<88S'RV7_E =$4]K]UKN+>G66,R 85E3T5 M575YQ.NAIHS5*V)073EGS\R[\]L-JJQZJJQI;&(G%5:I@=6ZII#'+V1R)["% ML9 51#&[?K6%,S9MU3OQSEEC[/K9HPVJD.Y:?6P0\TZZXRNJ78?)GVU0#3!0 M])'%?8>RY8 ?[))I+$!8.T2>NQCLV0) M^.PTXVLDK&9SWF:7,F6R='Z[)0+R7@("63A9FO%PN$0P%I,H8_#U(KF.3JR2,(,3UC.,^%TL=2YZDW-4H M_6@J2>>UQ=K\D#3I8*@26'"=9GPUVTV9^LAP6F*%.!*.G>[;8[R\^XY(<+\B M?-S=A]/'5($774H,Q#M! B5]I?[%/T7S'T\;RP2UYK0UY-RV0 +3M0RKBBU2 MFO7$K6?V;OXKAA[W&Z?'L[85[Q?N8V_K[C-G*)<.;]EL=FVBBJFL\':&U%9@ MK=*,]FG]SIOP!H>-?B$EY=_DX#BTAS0X(XW:(\.DUOQP# @V1P8I.=+MF!5Q MJW)?^>J'NH(KMP7ELOH=V/ RSVQ@)HWG&V&BDTW!PH#"EWS)Q)9NS-YNW/=Y M\@+J]+18)9H^H-H3;3XY'O.-!E3KOO9V?WX8G05\ME[;@L-1)DXS[-M2(I$X M'6ZJLIR@ 39Z5$M9^O 8L>+3!QW=LO2!\PR8,855VM..DJ21U MA7M<.??J=&NU,::*U0>:A7^2OJ\[NL$FS/[Z3,7R/G'9*-XUZNU9-M-KE=JUU MFNF4=J1?K5KEYKK>KM=:B7*CBFH_*I_*C8\U5&E>7M9;K7JSL0.=E9S.?B^W M/M4;']O-QD&BFJZDD23D<\4=Z.#NX>V\>7V9L&MTS+V[HB!PETDJY;7Q[I3' MBSMYZB2:>HGN_JA5/7?^V2P6SSM)Q!UG'Y+'QS^J/XZ/P2S\1SHOSQ$-'M$4 M?4S9=B'W8WB,3&Y,3H?7^6<76(=)/";A>H8^TI24K*NZ<8S&?6H1/A-[4X]& MHJ&GD;B_&YW>$;SPGLSC)#>'D[*FC;!Z38:Z805CY9LVNKJY;MV4&VW4;B(FS-I,8B$QBYK72,SO*?NH>8[:GVIH)N=F,JY< M:<-KL9C-[0(7[ X_G^M&PNH3U.7.3#0AV$!L#2),-YYG]>HSYKM*@KF M][8G$!H*KRNLI0'[KJ_@"9!*M#F6EX)8WD?H(H1%IU^5D6%,W;JW MK/:571M7\N??!5+X\;T0>M<6NN5S>R^C,UFZQ(;<1^#&"X3SP<*4BG-3.JO3 MWF4)[+GYL6895S\N1[7>LWONZ]T*[_J4E"3W-2WIV-+';Q^?N[/2S/->?E[# MA/UO"GO?JZ1G_O-9[_P^.QK07)C2LXM5= )9Z4M+&XCSFC@VP6I?$$X7+[.OOV9V@F>?8Z]['7->E1$\**+ @: M"&:Q^\N+JOBY^?/PIA@.BQTNLIB?CF3IK-YL7]1,1T,A$UD#HD,NW$*HFP>+1/)?6PP O9WH>=!4+-PARV/,E%5 M]E2&(,>DD.2_#[&BN+]OW%O/;L1T4T'6514/34:.^Q/?C#NUC,WK?R"&19D^ MZ@X6&U9G9^_44N9V/MP1[LQO9MA#M%&'?0G%_@!\10APL M,C3T!P#9@O%TM+@BK:0[6=+( U;P.NN2I2QPP<9S+&UYBA> &$#T6V3=0/X\ M\_%G&S_6G8 'F<_U*FVK^NLH7[XJML5OTZWT1OQ? M&PQ5?4*,'>5W_UJ]P-S3-3C#U=K2]A3UE^WV>U/@SDD^?*2N*04S3 M^>>":D0,UF5^?[N]I#<=<:++H>@RDK"HRP00 U[Z+!_=:Z*,=5U!K;X.QPVN ML'$_QI.U-R9J3W1;"N[VY#.M5?7S45D*QV$FB>MT6TJ66B-J$500A,AH;V%J M]"_.]=F@Z:^P'YM&6Q]KP9-_^5&4"DKW#RZ$Q//2TLF?D9(L.9S.QQ^>;[SY MYJN9JZ!-XXH9LTS96F)#?Y$[[4_GU5\/V7 ZFEW:T3ERDJ7*P@D/IW\+W3L* MZMZ5SFQU]2<=+G<07/[*#X^H6/BM/W_/V->[W-+>^:A)EHHYH9"/#("C L\] M9[!L=;^+A@;C!#K$*B*/1!Y9] '\FDQ'@DK8*W4$V@#Z0X=LNA2R'SAJL<+T MIA6F-R5<]N97IK(;\ $K@4'P\K7HZ_W7QZ8E&[TK$LY:Y-M3]K:?+!TM51[V M[>%?THL+'4XA]G5MY59BL?AG\.N7I1TVCL+IB6\K<9Z&9"E?%%(Y,1\OIPO+ MZ6PW[%__?22)AR?VRFH1E0QA!)'&A]"[EF+&).][,=V-GK68O#2H18F9L+.R$0A0<71]E36F^&KOH,S;"];DT%'5]&>N1_/YUO%)@17N= D6.XS M^USN8ZW'S',-ED'V9":&WHH"O@6QO.Q<@R.N)Z+4X(=5J2S\_[-T>X7!XQA?2Y",@68)L8#%+O I+G,VM)#5G M 5X>?GMKYAK2K][W\44WM&@X6/:# N&D8M!*XZ4QR62(J>#?R\XR\"T./*06 M5M$E-NZ)%3U_Q/8Y\MV:J+U7-U%?9:ICNW6[NO%"H.BV[=8:*,>Q\?JF)]1K M[/#Y=.48:FKH.S=VKF-CAPET2,GX!E2I-Z3US0UI--2>V#&_25BGID!()TET M)DCN$[80,@+N$;65&\\)+6HBC,9,TJ?N-7W,&B?8U#4XK66:(]BCPR922)=J M]@&NG)!W-:298@7*4AK=$M,>4.>X\,)VKO]@S7?6YA=HLN6T6.<-+CF07QC1 M1DT@FG ?BGF9#0CV6T(00X.^Q%KP=+>PFVP4(X0C1-,M]N3WB(+IP"R&+AR M-OCI>#/8E,C"L8'I;_S0NP.;J10/!(TSX$O\=S:C?M/5D69A@Q]L-I:DL/A, MKRJTVKZMY9YO=OL0$Q G.D=(C)3=[-H2I(S[A)\+\L/E&.V)^ZC/I : 1$%8 M5:=(\4*H0YP"K%(_:GQH\0@9%S@)!AQX#2DBD,+>:CU>=&@0F?!@$E%"/,^, MB?98?5WVOSEBVK+9U^'@,;(S];)OL#6/]3$V%X'./W;ZL,\$HJ:@/6D_ 7WL M$,+&>-3YQ7H Y7E1]A%0X=0#*35,3@0G$IM644 *GICI)\)EG20X=A(.\'Y: MV%J6L*96_"F5?Y;SW\X.PT%[0&!P,#W)TBWDS'T:]?8O#=VWW.TD7N*EP$$3 M((2!8T MB\&)J PDAJZ!9:E.$&%6Y@350:=G3 6Y<^;3@8!Q<, 6C/86O525\Z_2KX=PC@%D Z+C@^F)T1ZC?1G: MN26I,@H)PK+,T&Y@@"R(4# CM<"G<*E**O"%.6#+!&O%<.5-0M8'K&>3 U 2 MF%B%H>BAGJ&/K3YRWJ597P@GC-NL/(N5"?"'0%1).%E&'G\MGKC%GBS@$)>8 M$N<2,"T(6H)3> FM;DEF5<-2QI:?3DH*M!)VDKG>VX&"CNIXM8BIFE%5O5 6\/M*5. %]CRIIFS2*-D:^##?I 3:Z,:EB3 M*59!185T>D IW :G8$,Q$>3GH\JRZ++L'EYK$VC>>>+.]O-&V@.;'62:7<;# MQJY69\/%\9C D0AP0F#+(I ]$GB0L2-D8&7-XQ[?F'#/YR)LFDP=@4 LLMK0#=ASC9 &7>C#4_9+I6;WF5D!E^> M9=;>L-3G!6O"/JQOAP'9GSG;G%V5[WZR1[)N&,1-$ DN7V(8L/&I SH?J#XR MU8D+SJ!6EP!46KC#0VM9 ZL&E5>F32X':F$\O,A>7=>UR^=G %\3J$?!%WTL MHS<&[&YU[0FA#2HE!Y;.-%(;&S/(N #W@) +MNG&(DAV6>?;IDR JQ.3)C%M'4OK*<:P'RJ(\/T[I(:3*5^@,5F M2H*C.'M7(7O7E:$N+0K5E,B6HG2\__>&N_:,_3^S3U35M=K0GC]X=/4VU_ZZ MT7#^A)$M:'&E,Z-0R?[\K/WRY?<_D/R(?MI2^.D-O-KME9M8&A<:_' M( 'ZUH"?'D0/_!BSP^X/.C=:P"R#?6_G5YF??T:PS%L3Q-B%K]9\8[P+2A:K MS>20&EGV0LY4+J8!LF4?%ET[AH4MV,S2L\_ )VQ5S%LI!*BHV.0'812^@JI)^M:!LMGLVNM ,06!XEZ$YP3_6J"-!HIN M*42F ZPFD?.#R?>IX=9W7N%-JYHLB86#;"YWD#TJNBN 2YF[!+R???X=Z5J[ M3Q)V*C,.ESZ&/,#ZR.(>04"VFZ9BN=8EJ]SS B4N/<@R&[Q61)$@]R1PQ&Q<(R&*$]6\#!*[8XS_X9VW\A].[.B:CM M]J3:K-QCLKJ&??X5<@&^ M(J+<87UYSI@/A/,&OLT'QFU,UM+8-U^,7+*4\,08!$0.!$U]8M51[+/%H]B+ MG9]EDI+^X0>@'1\W@H/0]OEF>Q_>TXXS.M.&>!,K*W?J=B MWFX/SF&/I5Z=-F7OKO\MBRQ?%Q=/C#J4+$\RHVN7XZ.CYL71U^=?5>U34GSG M7SS-,UOONM)$5X;>)?PR5&:W5&87!BUUXTYG:#IO"W.VSH 4_0/B\E;PH S- MW/>+?N.^0,))B)S+!@R*2T*R=,U,SP&8[?GC'(^ ;AU>=HFUJK;^ZAQR?LZ]\C\'*QKWCW>03>XE2N M$')/];W (X,W4K;64Z&" I WEI>>%=#'SIYUDJ\>[N)A\\_B,!D$WZ+-#8R_I$%[?6N]L?("[N^P%J14K8&_MVH0!G5W29JOD',C MU1Z'*E,KF)R=)!JZ14*Y2?N9L_\(@Q?H\Y--+(8YEP=$4V#GO$I, MV:##Y:JQ00IELWQ1[A^&D^(VYPOT#Z+#]A8/1\Q4,,GT0/*T)&KH:2;F]L!- M[!P;G+YS#@KNN[L]94T;,;/C>AKF=ZXS TT44E^@WC.J6ZP;L.M3U^2TK\J* M[^3A?L+-2C AV$!V:.PE-N0^RHJVR]GW=9.MJ10,GFE[4\I85QAQ!DGQA GV M_I-F>J()/2USOS=EC0VA1>!MDV], MJZ;NN6W$J<#[24)FL@=3UHY]TEF=((4?0(/GT_LQS32XDVX@7(0[ MJ14[-M)+?_I5(XA>21+LCKN:R;2K\G4[4?\6BBB+0(\B)K%"GJQZNW:9$/-L M.?CQJ7Y6;[=0N5%%Y_5&N5&IER]0JUUF)6J--FI5/M6J-Q>UULM-K'\X=F-2 M0YV_=W/H/,Q;[)P.">G#/-5"/=;VV*<=:LUY!/_N7+>0%JEV@@*]ZU'+2OL\ M"V4+ZYI'7=W]@Z?9M!BU\YUO*$/L*49] RRDOF4-S>-,9CP>ITTBIWOZ0Z;, M3 CZ0,P,47K8R# ]&F?$0E80Q6R&&4MB7A3%0H[U51 *V6*&V/C/4D?/O<.: MXH1!*^F^-9@NOG!F/L7Z!0$?Q\CY+%DJ.^HQA+!=.]^A,K"=:L=I,#MHMD6# M]IQS4J"D\QI0=H].C:O%NPN1D_MHWN Z8LJY7=74'FG5*OPUZ1@CS#3_+%A1 M8H%31J=$L"^8'4"8RN^-Y8, $OP.#GQGTU*,NVCA+@!XS\;=V21U@<=F,,IB MF+T83^=B\18MF.7$F2>)W.E=A9BTMP[,*K//0)A5X3L-NX?LKJ: M)L?!!1U0^V H%X&M(>%G[;[9(>?V5^!QX^&<@7[#!0 SEHKA^V+PC:5DM. K M>2.$>0SPT%@'OHMAQW:>")-#DX."R=RADT 8\&$Z6#5F: :IS,#I'!.T+"SW M[4RC 4'-@(BA;C<)HC[C@U^?C@(1+D81"\& MHGP,HE<'T6$ART"4RV^"'Z^DNC+T 35--^H@$%/Y%9AJSQ*C!827M)< JSPT MJ(K$&%9!L"K$L(H*K IAB:5"#*&7A-!A#*%7A= A_"P4,MV<&!:"0O4DVC&+ M1<<8B['CQE48%>'$RJ'D>NM$X6XST;0.FD*529]'Z@2) M$D=3,4:3'TUQF, X[A., 7>EC8L"_ MWOB.*X,^,(3TB#D-NIKN"O.]*X/?QC[G$O2'>@0$9H5KC56)[&R/"3%B@Q ; M1W:\*F(E]E,V*W*/8$I<2_3-B[P.L<9P\[,W9DI.YY32=AYK)CF\)*.9IWRL2H]*$R^Y__A(-+?QJ;4&$T/6IE MGXVRCT6%@(B<(.6SN9R-B+5,*\]1$>?^Y7DVGMW<;K/0<)?YAVF\L1[V^OL\ MGA@$41"G 7L]@W!?VB;A>JCL?G7@' 2?A@_8ADCA .&!KO7F V_C@:VR%M8'.QTS8M+ M!+]V0PE4&%UT?Y<.!=0JOX ?)<;M:MS&@;L1PVW6OB&!L:DKR]>2X=]FURQ, MQ7G;8'WVXG898D,3ZK8Y:%_;8/ # VCK^PXQPE MLK_QHGF %1(.I#ED5J Z4$S'<&7.RC7[/J*Z>V<= M!+H$I62 :8XQ]7*8BJ.4(P:IM6*5F6Q21R9] $C]"P^&)XSB"5;9;TL,U-G9 M-7L;0,PMF*@K/5$5;"A4AXN 4$M71]SK=.#(Q?, #*\*E(XQG,SXDQ+O4L[A M%=F\I1/4Y&X4\Q@:<>XN/D'?X*H\]CI.]FU?PY&=R_6]ZD*$V>4=.4AX[QE] M=]Q/4'LR9 26#=RA\@F_5<6>FX8.(R[Y\F"[7_'D^W.M+Z,OSD6^$[G(?9=" MO'9RQ-=?I+>8^) )R,-0;!E_VL-8#?OKPV)=43A<2P$;#%5]XL3I.QJ7HW Y M)[H<)X2MS'S'OS%3D,IJJD49>GX'&SZ'\>FR%[5]XB,RT0 =>12%HXUR=8PZ MLRB4&?X@2DKV1$ .9]%;FFXYL9-C^T!-4+8<8(D8@B\*P?AD361.UJP5PUQG MZ#(MCC8(*C-JN"TN*S-I$!UD:';):(MNW'B,1P6@4G M\7]C/+TZGK*'W$ 3UY)4+;UKC2'VHDH>B*H/I]%9ZOO) MJ;A*+#Y/Z?P\T@B28C '@SD.TWQ]+!\>B6LKG;X4C?QD ;H:L::P29X2D5LZ MX%:(D16(K#C,*@(GO,6"YX3W1@!;ZX1WJ)#ZC#6^L^N(VOC(Z#RBXN2,44/4 M9CD3UI13X:9-B$&U&E1QT%,$0.5+1+*9'KB!CR1<:17G(UF!JCA;8U02DHC" M>AE)_L*P"O7T2IPYY"ELQ5O5$9!8SS>L%@^7OZ1ME8U!%0BJ>//YM?/Q" 4I ME]U 8 6&7;E>>6!].':)-=M;OQ!TM77$>6,]XD0["]D1XCWIU\:;F#N2CIZC M(+Z6Q54>]>#X=B%&5""BXMQ#$4+41H[!S2YO"=M#&,-J):SB#>((P6JCC-]N MNORMNRQB!*U$4)Q1)T((VNA6/A<<=LB1?1.M)\1^VSDP8ERMQ%4<8/&ZN!+! M"YA]EH]]R9F5E_("2GS;2A)C2,U!*HZPB!"D0K.A7BS((L;5$ES%0181PM66 M54 4J@X80^L):,61%J\-K:R4+^8WT (K!E&H]4K1ZD0I+H9I,,9:>PE(<*O&Z6)($X3!7V"38K\RZS3C\$AOWQ$+- M+F/:N7PS<\?RYP, /Z4K:?0=4VW,$S$ZF7(KS0-T<5%Q#_W;>2\<5X/T8GEK MI@W&./7C-(Z]B)#,>Y9OXTE:&!2RCMK- ME /-!,T7&/ZZTH08ER[3$1C?8I4I"C;GL=_>!Y-E9^OU?_Y:L+]W)LN*+I,Y MM["@K""A"LQ]E\V^>[W[E<&6.#ID[%9[)/*(7]S5[+(2Q'@W3"?%3!<>TTD; M,=TYU3#[D?W$KV&697VD\1M>WQN$+\FP4#X&)AG]K&[QI?TQQK9N%*BH>=^".NV&T'3&B(+Z!R5R_(L^T MUS65:@3].+N^0'7-M##H^5MS'BLYJUW0+X>&08(.52$#! M.ES QF88!$B5L0B"VS)1A\AX9+)J+--NQL(]$T&V74\;L$@YEP;P->"Q U?W-WZ1KW$4Z?P76+');> M^PF?=S7BLYJ-R(6(40"XY[I!*>0K$2/G/*QK<,6#14Q.#/N" 8DO]#(K"6!" M_+:QP9!H)K;@W-D0;C1G#WD* KMP.K)*6FCC%,K%*%M?$*]T@]_#P0EDJC9; M[\R9[.[C!Y#)A$W?@%K\*A"F=INCCO.;2888G/SJQ+,K,,N9R?=JW0Q_$*). MN9,6#4>&.8)L%):.,#+@9EV3WU+'J8#M"$DXJ>A:ERJ,"M#VVP;!_'8M_E(\ M>0?\$\ZVP?89R" /5!^9ZH23>,[#3M[#[+R-Z>%WT'/J8!N.@S0*2DO0;C2];#V?>WOIEZUM= [:VNFUW-3OME%KUCXUR M^^:ZUCK-=$J[T*F7G)Y5PF<;.I&CWR:<4!O0<*G!#1_35K*YFLS=VV(63",Q M;_^]I^Q["KAZ]"Q+MLR#'L1B-G?@U.P&\3!=G2GN< \#]Z IMB9OQP8#'1V" M3-9?]H(U"NZU#NECM0MA.5 1CQZV"_":#3+2V%>\0CRR^KK!^L>_A=(*G@ = M]FUZASR8.)=^_:E\&2:-'1XOYCYDO8:G'Y+2Q@,:\OI[5F^VK^N5>ON6$U=O M5-*^A3A2ALZ4F?+"/U%U]+IJ7-0)S!UNF<+HL$TT9R),JLXFQZM(FK/R.HM6 MWJNL/K24,3.$IC:DQ1Y0 M9S=1BW+S=9:X)7JU=RLX0G.?BB$T7&VSJIE3ZF!A2THW%=HY-;"-Q$#3!/]X;3 M@R!D^E*W7^Z_B5Z_H0F"S3U.G+O!M_N2]RGG611H?"NR):8JW@)Z&Z,?4_76 MJ=H^?L+;&0Q2@U]4N?VL]S54GF!-[ZGZ*"S5=O?9;K9O,CN$'*"8=GTGE/'L MA'*8>NKNC_8[U#X!F+;N.0-GM"8EFJP24Q5MV1F-?L94Q52]3?SLD&.UBA^H M@LII]J6)=UOU?!T]OTH-(ENZL;OC&BN9?\<@@$!;RW11&*TYB2:GQ%1%6T9& MHY\Q53%5;Q,_.Z1C5OK$M(B!OO./487V+3BM(FOD38QM[6TB<&I /T\ MT2*62]*C\GB"ZE7^PYUP=';'.DLTR/9K\B_Y9^3SX_DO1?C2NR]_[?_,E)7' M7U+S_G?V*E.>_+[MF=>5+X4?/[Y\^:Q(UY*<->]_&!??Z T^TSM]K7DDUV]^ MTM:CI=3-!IM193S^K8_4FZOZT2V^S.L&N2=_I,LN[>1$L?-X]#N7>9#.*C_N M/UZU+[NMK"9^'10MZ_*&]K7RX[T\^JS5:KE?^%+]69:OE4_#2O[W[46C5C!J MPZ_#^L?F[^^XT'-D4$L! A0#% @ ^Y[; M6-@WCW&\"P XY !4 ( !6P, &)T8WDM,C R-# S,S%? M;&%B+GAM;%!+ 0(4 Q0 ( /N>VUCLD/'SP < -Y> 5 M " 4H/ !B=&-Y+3(P,C0P,S,Q7W!R92YX;6Q02P$"% ,4 " #[GMM8 MWFO)=M@# 1%P "@ @ $]%P 97@R,RTQ+FAT;5!+ 0(4 M Q0 ( /N>VUC(QP[)4P@ ,=& * " 3T; !E>#,Q M+3$N:'1M4$L! A0#% @ ^Y[;6.,!C<1$" 7$4 H M ( !N", &5X,S$M,BYH=&U02P$"% ,4 " #[GMM8?P<0@T$$ !J$0 M"@ @ $D+ 97@S,BTQ+FAT;5!+ 0(4 Q0 ( /N>VU@W M-3C-900 ! = * " 8TP !E>#,R+3(N:'1M4$L! A0# M% @ ^Y[;6-"<4E$0)P %,"UK82YH=&U02P4& D "0 8 @ 55P end XML 23 form10-ka_htm.xml IDEA: XBRL DOCUMENT 0001630113 2023-04-01 2024-03-31 0001630113 2023-09-30 0001630113 2024-06-25 iso4217:USD shares iso4217:USD shares true FY 0001630113 10-K/A true 2024-03-31 --03-31 2024 false 000-56074 BIOTRICITY INC. NV 30-0983531 203 Redwood Shores Parkway Suite 600 Redwood City CA 94065 800 590-4155 Common Stock, Par Value $0.001 BTCY NASDAQ No No Yes Yes Non-accelerated Filer true false false false false 16344389 21484396 SRCO Professional Corporation Richmond Hill, Ontario, Canada 5828 The purpose of this Amendment No. 1 (the “Amendment”) to the Annual Report on Form 10-K of Biotricity Inc. (the “Company”) for the year ended March 31, 2024 (the “Original Form 10-K”) is to re-file the consent of the Company’s independent registered public accounting firm. In connection with the filing of this Amendment, the Company is also including with this Amendment certain currently dated certifications. Except as otherwise set forth in this Explanatory Note, no other information included in the Original Form 10-K is amended or changed by this Amendment.